Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy

Author(s): Shenglin Luo, Xiaochao Yang, Chunmeng Shi

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 5 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


The development of multifunctional theranostic agents has become an intriguing venture for personalized oncology, because they can integrate tumor diagnosis and therapy. One approach explored to obtain such multifunctional theranostic agents is through the chemical conjugation of anticancer drugs and contrast agents with various cancer-targeted ligands. The other approach is based on the nanoplatform, in which cancer-targeted nanostructures achieve simultaneous cancer specific detection and therapeutics either by EPR effect or by conjugation of target ligands. Interestingly, a newly emerging strategy from multifunctional small molecules to develop cancertargeted theranostic agents has been reported recently. In consideration of the urgent need and rapid development of theranostic agents in cancer therapy, herein we review the currently adopted and newly emerging approaches for their preparation, and highlight the promises and challenges in each approach, hoping to offer useful insights in developing more specific and efficient cancer theranostic agents suitable for clinical use.

Keywords: Cancer theranostics, multifunctional agents, near-infrared imaging, cyanine dyes, nanotheranostic agents.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 16 February, 2016
Page: [483 - 497]
Pages: 15
DOI: 10.2174/0929867323666151223095718
Price: $65

Article Metrics

PDF: 76
PRC: 7